| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 0.0 |
| Other income | 0.1 | 0.1 | 1.0 |
| Total income | 0.1 | 0.1 | 1.0 |
| Profit before exceptional items & tax | 0.1 | 0.0 | 0.9 |
| Profit before tax | 0.1 | 0.0 | 0.9 |
| Net profit | 0.3 | -1.6 | 0.7 |
| Operating margin | 100.0% | 0.0% | 90.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -57.10% |
|---|---|
| Operating profit, year on year | +100.00% |
| Operating profit, quarter on quarter | +100.00% |
Source
Read the filing ↗
BSE results filing, NSE: BACPHAR. Figures extracted from the filing.
Bacil Pharma Ltd: key numbers
- Share price
- ₹26.27
- Market cap
- ₹37.71 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 57.5×Sector 50.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bacil Pharma Ltd
All →
20:45 IST
BSE
Financial Results
Bacil Pharma Q4 FY26 Results: Net Profit ₹0.6 Cr, Up 50.0% YoY
Bacil Pharma Ltd reported net profit of ₹0.6 Cr (+50.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.6 Cr · +50.0% YoY